Article
Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza
2020-02-21
Abstract excerpt
<h4>Background: </h4> Host-derived inflammatory responses contribute to the morbidity and mortality of severe influenza, suggesting that immunomodulatory therapy may improve outcomes. The normally circulating protein, human plasma gelsolin, is available in recombinant form (rhu-pGSN) and has beneficial effects in a variety of pre-clinical models of inflammation and injury. <h4>Methods: </h4>: We evaluated delay...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ee164e03-dd4e-5e7e-ae8a-d28dd5610e96
- DOI
- 10.12688/f1000research.21082.2
